TCF7L1 has been shown to promote tumor growth in both xenograft models of human breast cancer (Slyper et al., 2012) and colorectal cancer (Murphy et al., 2016), but it is not clear whether TCF7L1 functions as an activator or repressor to exert its tumorigenic role. The gene discussed is TCF7L1; the disease is breast carcinoma.